GlassScriptPhysician profile
Jody Y Lin
NPI 1184711640
$2,393.23
in general payments reported to CMS, 2019-2025
26 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $59.72 · 2021: $120 · 2022: $711 · 2023: $693 · 2024: $143 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071 · Education: $87.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.61 |
| Education | $87.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $378.49 | 2023-2025 | Myfembree |
| Pfizer INC. | $214.00 | 2019-2025 | |
| Gynesonics, INC. | $172.40 | 2022 | |
| Myovant Sciences INC. | $160.57 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.55 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $132.38 | 2022-2025 | |
| Exact Sciences Corporation | $127.64 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $118.44 | 2019-2022 | |
| Abbvie INC. | $116.75 | 2019-2021 | |
| Coopersurgical, INC. | $115.86 | 2021-2025 | Paragard T 380a, Summit Doppler, Paragard T 380a |
| Medtronic, INC. | $104.55 | 2023 | Truclear |
| Mylan Pharmaceuticals INC. | $75.31 | 2022 | |
| Daiichi Sankyo INC. | $72.73 | 2022 | |
| Roche Diagnostics Corporation | $67.43 | 2019-2020 | |
| Exeltis, USA INC. | $63.87 | 2022-2025 | Slynd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $54.12 | 2023-2024 | Acessa Provu System |
| Astellas Pharma US INC | $51.91 | 2024-2025 | Veozah |
| Organon LLC | $43.51 | 2022-2024 | |
| Minerva Surgical, INC | $33.43 | 2019 | |
| Aspira Women'S Health INC | $32.63 | 2022 | |
| Boston Scientific Corporation | $29.65 | 2025 | Axonics |
| Convatec INC. | $22.89 | 2023 | |
| Amag Pharmaceuticals, INC. | $17.40 | 2019 | |
| Scynexis, INC. | $15.44 | 2022 | |
| Avion Pharmaceuticals | $14.30 | 2022 | |
| Merck Sharp & Dohme LLC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.